GOP senators remove $35 private insurance insulin cap from Democrats’ tax and climate bill

Republican senators on Sunday removed a $35 insulin cap for patients with private insurance from Democrats’ $740 billion tax and climate spending bill that the party will soon pass along party lines.

Democrats had sought to include the cap in private plans and health insurance, but the Senate congressman ruled it could not apply to private insurance under house budget rules that allow Democrats to approve the legislation by a simple majority and overthrow the filibuster.

As a result, 60 votes were needed — all Democrats and at least 10 Republicans — on an amendment to maintain the $35 insulin cap for private insurance companies in legislation known as the Cutback Act. inflation. He failed 57-43.

The seven GOP senators who sided with the 50 Democrats to pass the amendment were Susan Collins of Maine, Josh Hawley of Missouri, Cindy Hyde-Smith of Mississippi, John Kennedy and Bill Cassidy of Louisiana, and Dan Sullivan and Alaska’s Lisa Murkowski.

A separate Kennedy amendment to reallocate Obamacare funds to community health centers for discounted insulin for low- and middle-income Americans failed along party lines.

White House deputy press secretary Andrew Bates accused Republicans of choosing “corporate welfare over the middle class.”

READ ALSO: Most Americans Think US Economy Is Deteriorating: Poll

While the price cap for those with Medicare is a win for Democrats, excluding those with private insurance will mean millions of patients will continue to face rising insulin costs.

The Kaiser Family Foundation estimates that more than 1 in 5 insulin users with private insurance pay more than $35 a month, and Yale University found that 14% of the roughly 7 million Americans who need daily insulin users spend more than 40% of their income after food and housing on insulin.